Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 5/20 | 0.58 |
| ▸ | BMP1 | P13497 | 1/20 | 0.49 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.47 |
| ▸ | GNPAT | O15228 | 1/20 | 0.45 |
| ▸ | ENPEP | Q07075 | 7/20 | 0.43 |
| ▸ | ANPEP | P15144 | 2/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6810241 | 0.91 | FOLH1 (0.61) | FOLH1BMP1RIMKLANAALAD2PTGS1 | |
| SCHEMBL7461963 | 0.91 | FOLH1 (0.61) | FOLH1BMP1RIMKLANAALAD2PTGS1 | |
| SCHEMBL7461950 | 0.91 | FOLH1 (0.61) | FOLH1BMP1RIMKLANAALAD2PTGS1 | |
| SCHEMBL6810234 | 0.91 | FOLH1 (0.61) | FOLH1BMP1RIMKLANAALAD2PTGS1 | |
| SCHEMBL30798162 | 0.91 | FOLH1 (0.55) | FOLH1RIMKLANAALAD2GNPATENPEP | |
| SCHEMBL29517538 | 0.91 | FOLH1 (0.55) | FOLH1BMP1RIMKLANAALAD2GNPAT | |
| SCHEMBL28489878 | 0.91 | FOLH1 (0.55) | FOLH1BMP1RIMKLANAALAD2GNPAT | |
| SCHEMBL29511419 | 0.91 | FOLH1 (0.55) | FOLH1BMP1RIMKLANAALAD2GNPAT | |
| SCHEMBL29682236 | 0.91 | FOLH1 (0.55) | FOLH1RIMKLANAALAD2GNPATENPEP | |
| SCHEMBL10165828 | 0.91 | FOLH1 (0.58) | FOLH1BMP1RIMKLANAALAD2GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | disclosed |
| CN-113845564-B | Rosa roxburghii antioxidant oligopeptide, preparation method and application thereof and antioxidant product | 中国农业大学 | 2023-06-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | CA9, CA13, CA4 | FOLH1 36/4885BMP1 153/4885RIMKLA 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.